TAI · 1795.TW
Lotus Pharmaceutical Co., Ltd.
NT$167.50-NT$5.00 (-2.9%)
Lotus Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 54.67% below the high.
Loading market information…
TAI · 3705.TW · TWD
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 05:30 AM UTC. Cached market data; not a live quote.
One-year closing-price history · TWD. Historical prices are not a forecast.
YungShin Global Holding Corporation’s quoted price sits in the upper half of its reported 52-week range, 3.71% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
YungShin Global Holding Corporation’s forward annual dividend is NT$3.00 per share, paid annual. The forward yield is 5.03% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow YungShin Global Holding Corporation’s reporting calendar.
THE COMPANY BEHIND THE TICKER
YungShin Global Holding Corporation, through its various subsidiaries, engages in strategic investments, production, and distribution across a diverse portfolio. Its primary focus lies in the manufacturing and sale of human and veterinary pharmaceuticals, agricultural chemicals, industrial medical products, and cosmetics. The company maintains a significant market presence in Taiwan, Mainland China, Japan, and the United States. Beyond these core areas, YungShin also processes and markets wood products. Its operations include the development and sale of over-the-counter medications, specialized preparations, and chemical intermediates. Furthermore, the corporation offers a range of pharmaceutical services, such as research and development, technology transfer, licensing, and outsourcing, alongside general import and export trading activities. The company's commercial reach extends to the wholesale, retail, and broader trading of health products, beauty items, medical supplies, human testing reagents, and all associated raw materials, semi-finished goods, and manufacturing equipment. Established in 1952, YungShin Global Holding Corporation is headquartered in Taichung, Taiwan.
Latest available per-share figures in TWD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 09:01 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
NT$167.50-NT$5.00 (-2.9%)
Lotus Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 54.67% below the high.
NT$28.55-NT$0.80 (-2.73%)
Center Laboratories, Inc.’s quoted price sits in the lower half of its reported 52-week range, 41.69% below the high.
NT$79.90-NT$0.50 (-0.62%)
TTY Biopharm Company Limited’s quoted price sits in the upper half of its reported 52-week range, 8.16% below the high.
NT$20.00+NT$0.10 (+0.5%)
ScinoPharm Taiwan, Ltd.’s quoted price sits in the lower half of its reported 52-week range, 31.27% below the high.
NT$28.80-NT$0.15 (-0.52%)
Synmosa Biopharma Corporation’s quoted price sits in the lower half of its reported 52-week range, 8.54% below the high.
NT$56.70-NT$0.20 (-0.35%)
Standard Chem & Pharm Co. Ltd.’s quoted price sits in the upper half of its reported 52-week range, 6.36% below the high.
NT$30.55-NT$0.20 (-0.65%)
Sinphar Pharmaceutical Co. Ltd.’s quoted price sits in the upper half of its reported 52-week range, 6.86% below the high.
NT$51.00-NT$0.60 (-1.16%)
SCI Pharmtech, Inc.’s quoted price sits in the upper half of its reported 52-week range, 15.98% below the high.
